Maximilian Lennartz
Overview
Explore the profile of Maximilian Lennartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Bedke T, Stumme F, Tomczak M, Steglich B, Jia R, Bohmann S, et al.
Gut
. 2024 Jun;
73(8):1292-1301.
PMID: 38839272
Objective: There is a strong clinical association between IBD and primary sclerosing cholangitis (PSC), a chronic disease of the liver characterised by biliary inflammation that leads to strictures and fibrosis....
22.
Menz A, Lony N, Lennartz M, Rico S, Schlichter R, Kind S, et al.
Diagnostics (Basel)
. 2024 May;
14(10).
PMID: 38786342
EpCAM is expressed in many epithelial tumors and is used for the distinction of malignant mesotheliomas from adenocarcinomas and as a surrogate pan-epithelial marker. A tissue microarray containing 14,832 samples...
23.
Boroojerdi S, Weidemann S, Menz A, Lennartz M, Rico S, Schlichter R, et al.
APMIS
. 2024 May;
132(7):479-491.
PMID: 38757248
The Melan-A (melanocyte antigen) protein, also termed 'melanoma antigen recognized by T cells 1' (MART-1) is a protein with unknown function whose expression is specific for the melanocyte lineage. Antibodies...
24.
Plage H, Furlano K, Hofbauer S, Weinberger S, Ralla B, Franz A, et al.
BMC Urol
. 2024 Apr;
24(1):96.
PMID: 38658905
Background: A high level of PD-L1 expression is the most relevant predictive parameter for response to immune checkpoint inhibitor (CPI) therapy in urinary bladder cancer. Existing data on the relationship...
25.
Lennartz M, Lohr N, Hoflmayer D, Rico S, von Bargen C, Kind S, et al.
Am J Surg Pathol
. 2024 Apr;
48(6):637-651.
PMID: 38647255
Trichorhinophalangeal syndrome 1 (TRPS1) is a nuclear protein highly expressed in breast epithelial cells. TRPS1 immunohistochemistry (IHC) has been suggested as a breast cancer marker. To determine the diagnostic and...
26.
Lennartz M, Amezada D, Hoflmayer D, Rico S, von Bargen C, Kind S, et al.
Arch Pathol Lab Med
. 2024 Mar;
148(12):1327-1336.
PMID: 38484775
Context.—: Steroidogenic acute regulatory (StAR) protein is a mitochondrial transport protein with a critical regulatory role for steroid hormone production. The tissue distribution of StAR expression is limited to few...
27.
Debatin N, Bady E, Mandelkow T, Huang Z, Lurati M, Raedler J, et al.
Eur Urol
. 2024 Feb;
86(1):42-51.
PMID: 38383257
Background And Objective: Quantity and the spatial relationship of specific immune cell types can provide prognostic information in bladder cancer. The objective of the study was to characterize the spatial...
28.
Muller J, Plage H, Elezkurtaj S, Mandelkow T, Huang Z, Lurati M, et al.
Front Oncol
. 2024 Jan;
13:1342367.
PMID: 38282671
Introduction: Trophoblast cell surface antigen 2 (TROP2; EpCAM2) is a transmembrane glycoprotein which is closely related to EpCAM (EpCAM; EpCAM1). Both proteins share partial overlapping functions in epithelial development and...
29.
Lennartz M, Benjamin Dunnebier N, Hoflmayer D, Rico S, Kind S, Reiswich V, et al.
Am J Surg Pathol
. 2024 Jan;
48(4):377-386.
PMID: 38271200
Glutamate decarboxylase 2 (GAD2) is the most important inhibitory neurotransmitter and plays a role in insulin-producing β cells of pancreatic islets. The limitation of GAD2 expression to a few normal...
30.
Viehweger F, Bocker C, Weidemann S, Freytag M, Menz A, Buscheck F, et al.
Diagn Pathol
. 2024 Jan;
19(1):12.
PMID: 38218896
Background: Prostein (P501S), also termed solute carrier family 45 member 3 (SLC45A3) is an androgen regulated protein which is preferentially expressed in prostate epithelial cells. Because of its frequent expression...